Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI

European Radiology

Volumn 22, Issue 8, 2012, Pages 1769-1775

  Denecke, Timm ^a   Steffen, Ingo G ^a   Agarwal, Sheela ^b   Seehofer, Daniel ^a   Kröncke, Thomas ^a   Hänninen, Enrique Lopez ^a   Kramme, Incken Birthe ^a   Neuhaus, Peter ^a   Saini, Sanjay ^b   Hamm, Bernd ^a   Grieser, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adenoma; Gadoxetic acid; Hepatocellular adenoma; Liver; MRI

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HEPATOCELLULAR ADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CANCER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADENOMA, LIVER CELL; ADULT; AGED; ARTERIES; BIOPSY; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864677998     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2422-5     Document Type: Article

References (36)

1. Soe KL, Soe M, Gluud C (1992) Liver pathology associated with the use of anabolic-Androgenic steroids. Liver 12:73-9
2. van den Esschert JW, van Gulik TM, Phoa SS (2010) Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg 27:46-55
3. van der Windt DJ, Kok NF, Hussain SM, Zondervan PE, Alwayn IP, de Man RA et al (2006) Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 93:1495-502
4. Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Sahani DV (2011) Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management. Radiology 258:673-93
5. Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 7:186-96
6. Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12:509-22
7. Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19:342-57
8. Morana G, Grazioli L, Kirchin MA, Bondioni MP, Faccioli N, Guarise A et al (2011) Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol 46:225-39
9. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ et al (2005) Efficacy and safety of MR imaging with liverspecific contrast agent: US multicenter phase III study. Radiology 237:89-98
10. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L et al (2006) Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT-A multicenter trial. J Comput Assist Tomogr 30:345-54
11. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J et al (2005) Enhancement of focal liver lesions at gadoxetic acidenhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468-78
12. Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195:13-28
13. Huppertz A, Breuer J, Fels LM, Schultze-Mosgau M, Sutter G, Klein S et al (2011) Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP). J Magn Reson Imaging 33:409-16
14. Leonhardt M, Keiser M, Oswald S, Kuhn J, Jia J, Grube M et al (2010) Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos 38:1024-8
15. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K et al (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793-8
16. van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290:153-7
17. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785-92
18. Kato N, Yokawa T, Tamura A, Heshiki A, Ebert W, Weinmann HJ (2002) Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats. Invest Radiol 37:680-4
19. Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M et al (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824-33
20. Giovanoli O, Heim M, Terracciano L, Bongartz G, Ledermann HP (2008) MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol 190:W290-3
21. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48:163-70
22. Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F et al (1985) Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 89:1132-8
23. Arrive L, Flejou JF, Vilgrain V, Belghiti J, Najmark D, Zins M et al (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193:507-12
24. Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D (1995) Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 165:303-8
25. Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166-77
26. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J (2006) Hepatocellular adenoma: findings at state-ofthe-Art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 16:1873-86
27. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME (1994) Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 163:113-6
28. van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172-81
29. Vetelainen R, Erdogan D, de Graaf W, ten Kate F, Jansen PL, Gouma DJ et al (2008) Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 28:499-508
30. Lewin M, Handra-Luca A, Arrive L, Wendum D, Paradis V, Bridel E et al (2006) Liver adenomatosis: classification ofMR imaging features and comparison with pathologic findings. Radiology 241:433-40
31. Ricci P, Cantisani V, D'Onofrio M, Sahani D, Pagliara E, Calliada F et al (2008) Behavior of hepatocellular adenoma on real-Time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent. J Ultrasound Med 27:1719-26
32. Bioulac-Sage P, Balabaud C, Zucman-Rossi J (2010) Focal nodular hyperplasia, hepatocellular adenomas: past, present, future. Gastroenterol Clin Biol 34:355-8
33. Bioulac-Sage P, Balabaud C, Zucman-Rossi J (2010) Subtype classification of hepatocellular adenoma. Dig Surg 27:39-45
34. Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J (2007) Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 13:2649-54
35. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481-9
36. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740-8